Electrostatic reaction for the detection of circulating tumor cells as a potential diagnostic biomarker for metastasis in solid tumor
The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification and identification of CTCs in solid tumors remain a challenge. Aerobic glycolysis is a hallmark of cancer cells, which makes cancer cells ha...
Saved in:
| Published in | Nanotheranostics (Sydney, NSW) Vol. 4; no. 4; pp. 233 - 241 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Australia
Ivyspring International Publisher
2020
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2206-7418 2206-7418 |
| DOI | 10.7150/ntno.46928 |
Cover
| Abstract | The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification and identification of CTCs in solid tumors remain a challenge. Aerobic glycolysis is a hallmark of cancer cells, which makes cancer cells have more negative membrane potentials than that of normal cells. Herein, we reported a CTC isolation method with 80.7% capture efficiency based on electrostatic reaction, which was accomplished within 30 min in mimic clinical samples. Following
verification using Lewis lung carcinoma (LLC1) (EpCAM-positive) and B16F10 (EpCAM-negative) melanoma cells, syngeneic tumor models were used to evaluate specificity and sensitivity of the surface charged nanoparticles. After subcutaneous implantation, blood was drawn from mice every three days, and CTCs were successfully detected in all implanted subjects. From 100 µl blood samples, the minimum amount found in blood was 9-34 CTCs on 3 day and the maximum was 94-107 CTCs on 15 day. Besides, the isolated CTCs cells remained viable and verified by re-implantation. This study confirms that our multifunctional nanoparticles are highly efficient in detecting CTCs in tumor metastasis and has huge potential in translational medicine. |
|---|---|
| AbstractList | The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification and identification of CTCs in solid tumors remain a challenge. Aerobic glycolysis is a hallmark of cancer cells, which makes cancer cells have more negative membrane potentials than that of normal cells. Herein, we reported a CTC isolation method with 80.7% capture efficiency based on electrostatic reaction, which was accomplished within 30 min in mimic clinical samples. Following in vitro verification using Lewis lung carcinoma (LLC1) (EpCAM-positive) and B16F10 (EpCAM-negative) melanoma cells, syngeneic tumor models were used to evaluate specificity and sensitivity of the surface charged nanoparticles. After subcutaneous implantation, blood was drawn from mice every three days, and CTCs were successfully detected in all implanted subjects. From 100 µl blood samples, the minimum amount found in blood was 9-34 CTCs on 3 day and the maximum was 94-107 CTCs on 15 day. Besides, the isolated CTCs cells remained viable and verified by re-implantation. This study confirms that our multifunctional nanoparticles are highly efficient in detecting CTCs in tumor metastasis and has huge potential in translational medicine. The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification and identification of CTCs in solid tumors remain a challenge. Aerobic glycolysis is a hallmark of cancer cells, which makes cancer cells have more negative membrane potentials than that of normal cells. Herein, we reported a CTC isolation method with 80.7% capture efficiency based on electrostatic reaction, which was accomplished within 30 min in mimic clinical samples. Following in vitro verification using Lewis lung carcinoma (LLC1) (EpCAM-positive) and B16F10 (EpCAM-negative) melanoma cells, syngeneic tumor models were used to evaluate specificity and sensitivity of the surface charged nanoparticles. After subcutaneous implantation, blood was drawn from mice every three days, and CTCs were successfully detected in all implanted subjects. From 100 µl blood samples, the minimum amount found in blood was 9-34 CTCs on 3 day and the maximum was 94-107 CTCs on 15 day. Besides, the isolated CTCs cells remained viable and verified by re-implantation. This study confirms that our multifunctional nanoparticles are highly efficient in detecting CTCs in tumor metastasis and has huge potential in translational medicine.The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification and identification of CTCs in solid tumors remain a challenge. Aerobic glycolysis is a hallmark of cancer cells, which makes cancer cells have more negative membrane potentials than that of normal cells. Herein, we reported a CTC isolation method with 80.7% capture efficiency based on electrostatic reaction, which was accomplished within 30 min in mimic clinical samples. Following in vitro verification using Lewis lung carcinoma (LLC1) (EpCAM-positive) and B16F10 (EpCAM-negative) melanoma cells, syngeneic tumor models were used to evaluate specificity and sensitivity of the surface charged nanoparticles. After subcutaneous implantation, blood was drawn from mice every three days, and CTCs were successfully detected in all implanted subjects. From 100 µl blood samples, the minimum amount found in blood was 9-34 CTCs on 3 day and the maximum was 94-107 CTCs on 15 day. Besides, the isolated CTCs cells remained viable and verified by re-implantation. This study confirms that our multifunctional nanoparticles are highly efficient in detecting CTCs in tumor metastasis and has huge potential in translational medicine. The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification and identification of CTCs in solid tumors remain a challenge. Aerobic glycolysis is a hallmark of cancer cells, which makes cancer cells have more negative membrane potentials than that of normal cells. Herein, we reported a CTC isolation method with 80.7% capture efficiency based on electrostatic reaction, which was accomplished within 30 min in mimic clinical samples. Following verification using Lewis lung carcinoma (LLC1) (EpCAM-positive) and B16F10 (EpCAM-negative) melanoma cells, syngeneic tumor models were used to evaluate specificity and sensitivity of the surface charged nanoparticles. After subcutaneous implantation, blood was drawn from mice every three days, and CTCs were successfully detected in all implanted subjects. From 100 µl blood samples, the minimum amount found in blood was 9-34 CTCs on 3 day and the maximum was 94-107 CTCs on 15 day. Besides, the isolated CTCs cells remained viable and verified by re-implantation. This study confirms that our multifunctional nanoparticles are highly efficient in detecting CTCs in tumor metastasis and has huge potential in translational medicine. |
| Author | Liu, Xingping Zhuang, Xuan Zhang, Weidong Li, Zhiming |
| AuthorAffiliation | 2 Department of Urology, the First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China 3 Clinical Trial Management Platform, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang, China 1 Institue of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China 4 Department of Clinical Medicine, Fujian Medical University, Fuzhou 350005, Fujian Province, China |
| AuthorAffiliation_xml | – name: 4 Department of Clinical Medicine, Fujian Medical University, Fuzhou 350005, Fujian Province, China – name: 1 Institue of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China – name: 2 Department of Urology, the First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China – name: 3 Clinical Trial Management Platform, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang, China |
| Author_xml | – sequence: 1 givenname: Zhiming surname: Li fullname: Li, Zhiming – sequence: 2 givenname: Xingping surname: Liu fullname: Liu, Xingping – sequence: 3 givenname: Weidong surname: Zhang fullname: Zhang, Weidong – sequence: 4 givenname: Xuan surname: Zhuang fullname: Zhuang, Xuan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32923313$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UV1rFTEQDVKxtfbFHyB5FOXWfN29uy-ClGoLhb7U5zCbzN5Gs8k1ySr9Af5vs93WVhEhkGHmzDkzZ56TvRADEvKSs-MNX7N3oYR4rJpOtE_IgRCsWW0Ub_cexfvkKOcvjDHecSFl94zsS9HViMsD8vPUoykp5gLFGZoQTHEx0CEmWq6RWiy4ZOJAjUtm8hUYtrRMY4UY9D5TqI_uYsFQHHhqHWxDZax8vYsjpK-YbglHLFCFssvUBZqjd3bheUGeDuAzHt39h-Tzx9Ork7PVxeWn85MPFysjOtmuLAxdw5hVzTAwzjq0aEC0_drMCcMkCrkB01noOQxcoLQK-bpR0vRNt2bykLxdeKewg5sf4L3eJVcnvNGc6dlPPfupb_2s6PcLejf1I1pT10vw0BHB6T8rwV3rbfyuN6pVjRSV4PUdQYrfJsxFjy7PlkHAOGUtlBIN44rJCn31WOu3yP2lKoAtAFOPlRMO2rj5ZnGWdv7f87_5q-U_y_4CyBe63A |
| CitedBy_id | crossref_primary_10_1021_acsami_3c15879 crossref_primary_10_1111_cas_15049 crossref_primary_10_3390_pharmaceutics15010280 |
| ContentType | Journal Article |
| Copyright | The author(s). The author(s) 2020 |
| Copyright_xml | – notice: The author(s). – notice: The author(s) 2020 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
| DOI | 10.7150/ntno.46928 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering |
| EISSN | 2206-7418 |
| EndPage | 241 |
| ExternalDocumentID | 10.7150/ntno.46928 PMC7484632 32923313 10_7150_ntno_46928 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION GROUPED_DOAJ HYE M~E OK1 PGMZT RPM CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c2938-daf9600d46ff0109edeca28b5c6ff0c03e237ac9dab1af12e3d4e15643cb69503 |
| IEDL.DBID | UNPAY |
| ISSN | 2206-7418 |
| IngestDate | Sun Oct 26 02:54:07 EDT 2025 Tue Sep 30 16:44:12 EDT 2025 Fri Jul 11 07:20:41 EDT 2025 Thu Jan 02 22:57:58 EST 2025 Thu Apr 24 23:12:19 EDT 2025 Tue Jul 01 01:14:46 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Nanoparticles Circulating tumor cells (CTCs) Syngeneic tumor models Bioelectricity |
| Language | English |
| License | The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2938-daf9600d46ff0109edeca28b5c6ff0c03e237ac9dab1af12e3d4e15643cb69503 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: The authors have declared that no competing interest exists. |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.ntno.org/v04p0233.pdf |
| PMID | 32923313 |
| PQID | 2442601403 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | unpaywall_primary_10_7150_ntno_46928 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7484632 proquest_miscellaneous_2442601403 pubmed_primary_32923313 crossref_citationtrail_10_7150_ntno_46928 crossref_primary_10_7150_ntno_46928 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-00-00 |
| PublicationDateYYYYMMDD | 2020-01-01 |
| PublicationDate_xml | – year: 2020 text: 2020-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Australia |
| PublicationPlace_xml | – name: Australia – name: Sydney |
| PublicationTitle | Nanotheranostics (Sydney, NSW) |
| PublicationTitleAlternate | Nanotheranostics |
| PublicationYear | 2020 |
| Publisher | Ivyspring International Publisher |
| Publisher_xml | – name: Ivyspring International Publisher |
| SSID | ssj0001912339 |
| Score | 2.116221 |
| Snippet | The detection of circulating tumor cells (CTCs) from blood samples is important to predict metastatic spread of cancer cells. However, effective quantification... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 233 |
| SubjectTerms | Animals Biomarkers, Tumor - blood Cell Line, Tumor Cells, Cultured Magnetite Nanoparticles - chemistry Mice Mice, Inbred C57BL Models, Biological Neoplasm Metastasis - diagnosis Neoplasm Metastasis - pathology Neoplastic Cells, Circulating - chemistry Neoplastic Cells, Circulating - pathology Research Paper Static Electricity |
| Title | Electrostatic reaction for the detection of circulating tumor cells as a potential diagnostic biomarker for metastasis in solid tumor |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32923313 https://www.proquest.com/docview/2442601403 https://pubmed.ncbi.nlm.nih.gov/PMC7484632 https://www.ntno.org/v04p0233.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2206-7418 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001912339 issn: 2206-7418 databaseCode: DOA dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2206-7418 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001912339 issn: 2206-7418 databaseCode: M~E dateStart: 20160101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 2206-7418 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001912339 issn: 2206-7418 databaseCode: RPM dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6V7QE4lDcsj8oVvXBISWLHmz1WqFWFRMWBlcopcvyAiK2z2k1A9N7_3Rl7d9lSVCHlZE9syx7L39gz3wDsG1WMM5XbxGWZTESpVFJqLZNaOulMXcrS0j3kp1N5MhEfz4qzLdhbxcIEp_3Ot-ER_2cqZnimoLVn3B3YlgXC7QFsT04_H36lpHE5WsPEvhJpR0eIbd6Hf9Hko-zqmwfNDfR40wnybu9n6vcvNZ1unDDHD_7E6UTHkh8HfVcf6Iu_aBtvHfxD2FniS3YYFeIRbFn_GO5vsA4-gcujmPqGYokazRA1htgGhvCVIRxkxnY2lrSO6WauQ4Yv_411_TmK0FX_gin82KztyNkI-zPRY4_ao4B-8vmZhwbPbaewo0WzYI1nqOiNie08hcnx0ZcPJ8kyG0OiERKUiVEOpz81QjpH72nWWK3ysi40FeiU25yPlB4bVWfKZbnlRliiouG6luMi5c9g4FtvXwAbCSFsUZcGwZ1QwiniHNJWccQu2qXlEN6tlq7SS6pyypgxrdBkoWWuaJarsMxDeLuWnUWCjn9K7a00oML9QzOlvG37RYXwhljVRMqH8DxqxLodniP85RnWjK7pylqAuLmv1_jme-DoJopWyfMh7K-16pbhvfw_sVdwLydzP9wAvYZBN-_tG8REXb0b7hJ2l3vjCjNfFSY |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6V7QE4lDcsL7miFw4pSex4s8cKtaqQqDiwUjlFjh80YuusdhNQe-__ZsbeXbYUVUg52RPbssfyN_bMNwB7RhXjTOU2cVkmE1EqlZRay6SWTjpTl7K0dA_5-UQeT8Sn0-J0C3ZXsTDBab_zbXjE_5mKGZ4paO0Zdwe2ZYFwewDbk5MvB98oaVyO1jCxr0Ta0RFimw_hXzT5KLv65kFzAz3edIK82_uZuvilptONE-bowZ84nehY8mO_7-p9ffkXbeOtg38IO0t8yQ6iQjyCLesfw_0N1sEncHUYU99QLFGjGaLGENvAEL4yhIPM2M7GktYx3cx1yPDlv7OuP0cRuupfMIUfm7UdORthfyZ67FF7FNBPPj_z0OC57RR2tGgWrPEMFb0xsZ2nMDk6_PrxOFlmY0g0QoIyMcrh9KdGSOfoPc0aq1Ve1oWmAp1ym_OR0mOj6ky5LLfcCEtUNFzXclyk_BkMfOvtC2AjIYQt6tIguBNKOEWcQ9oqjthFu7QcwvvV0lV6SVVOGTOmFZostMwVzXIVlnkI79ays0jQ8U-p3ZUGVLh_aKaUt22_qBDeEKuaSPkQnkeNWLfDc4S_PMOa0TVdWQsQN_f1Gt-cBY5uomiVPB_C3lqrbhney_8TewX3cjL3ww3Qaxh0896-QUzU1W-Xu-I3ujcUMQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Electrostatic+reaction+for+the+detection+of+circulating+tumor+cells+as+a+potential+diagnostic+biomarker+for+metastasis+in+solid+tumor&rft.jtitle=Nanotheranostics+%28Sydney%2C+NSW%29&rft.au=Li%2C+Zhiming&rft.au=Liu%2C+Xingping&rft.au=Zhang%2C+Weidong&rft.au=Zhuang%2C+Xuan&rft.date=2020&rft.eissn=2206-7418&rft.volume=4&rft.issue=4&rft.spage=233&rft_id=info:doi/10.7150%2Fntno.46928&rft_id=info%3Apmid%2F32923313&rft.externalDocID=32923313 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2206-7418&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2206-7418&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2206-7418&client=summon |